| Patents for C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media (9,992) |
|---|
| 02/08/2006 | EP1623015A2 Dna vaccine expressing ha1 of equine-2 influenza virus |
| 02/08/2006 | EP1623014A2 Dielectrophoresis apparatus |
| 02/08/2006 | EP1623013A2 Methods for identification of coronaviruses |
| 02/08/2006 | EP1623012A2 ANTISENSE ANTIVIRAL AGENT AND METHOD FOR TREATING ssRNA VIRAL INFECTION |
| 02/08/2006 | EP1623011A2 IL-23p40 SPECIFIC IMMUNOGLOBULIN DERIVED PROTEINS, COMPOSITIONS, METHODS AND USES |
| 02/08/2006 | EP1623010A2 Preservation of rna in a biological sample |
| 02/08/2006 | EP1623008A2 Pufa polyketide synthase systems and uses thereof |
| 02/08/2006 | EP1623006A2 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus |
| 02/08/2006 | EP1623004A2 Genetic markers for skatole metabolism |
| 02/08/2006 | EP1622935A2 Spex compositions and methods of use |
| 02/08/2006 | EP1622927A2 Love variant regulator molecules |
| 02/08/2006 | EP1622923A2 Molecular detection systems utilizing reiterative oligonucleotide synthesis |
| 02/08/2006 | EP1622635A2 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins |
| 02/08/2006 | EP1622634A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 02/08/2006 | EP1622540A2 Formulations for cell- schedule dependent anticancer agents |
| 02/07/2006 | US6995015 Pathogen-resistant grape plants |
| 02/02/2006 | WO2005021715A3 Methods for improving growth and crop productivity of plants by adjusting plant hormone levels, ratios and/or co-factors |
| 02/02/2006 | WO2005014775A3 Raav compositions and methods for delivery of human factor vii polypeptides and treatment of hemophilia a |
| 02/02/2006 | WO2005003301A3 Methods, compositions, and kits for predicting the effect of compounds on hot flash symptoms |
| 02/02/2006 | WO2005001039A3 Ribozyme-regulated small inhibitory rna (sirna) production and methods of use thereof |
| 02/02/2006 | WO2005001038A3 Recombinant anti-cd30 antibodies and uses thereof |
| 02/02/2006 | WO2004113503A3 Mbms as modifiers of branching morphogenesis and methods of use |
| 02/02/2006 | WO2004108886A3 Anti-hiv-1 compounds based upon a conserved amino acid sequence shared by gp160 and the human cd4 protein |
| 02/02/2006 | WO2004101753A3 Codon-optimized genes for the production of polyunsaturated fatty acids in oleaginous yeasts |
| 02/02/2006 | WO2004097004A3 Trasngenic expression of a phytochrome a gene |
| 02/02/2006 | WO2004092352A3 Disruption of the reg pathway |
| 02/02/2006 | US20060024675 Nucleic acid probes and broad-range primers from regions in topoisomerase genes, and methods in which they are used |
| 02/01/2006 | EP1620728A2 Chromatographic assay system |
| 02/01/2006 | EP1620722A2 Methods for characterizing signaling pathways and compounds that interact therewith |
| 02/01/2006 | EP1620569A2 A forward mutation assay based on 5-fluorouracil resistance |
| 02/01/2006 | EP1620561A2 A delta-12 desaturase gene suitable for altering levels of polyun saturated fatty acids in oleaginous yeasts |
| 02/01/2006 | EP1620547A2 Stabilized aptamers to platelet derived growth factor and their use as oncology therapeutics |
| 02/01/2006 | EP1620545A2 Disease prevention and vaccination following thymic reactivation |
| 02/01/2006 | EP1620544A2 MODIFIED iRNA AGENTS |
| 02/01/2006 | EP1620543A2 Production of polyunsaturated fatty acids in oleaginous yeasts |
| 02/01/2006 | EP1620542A2 Codon-optimized genes for the production of polyunsaturated fatty acids in oleaginous yeasts |
| 02/01/2006 | EP1620538A2 Trasngenic expression of a phytochrome a gene |
| 02/01/2006 | EP1620537A2 Large volume ex vivo electroporation method |
| 02/01/2006 | EP1620536A2 Molecular haplotyping of genomic dna |
| 02/01/2006 | EP1620126A2 Disease prevention and vaccination prior to thymic reactivations |
| 02/01/2006 | EP1461052A4 Nucleic acid injected into hepatic vein lumen and delivered to primate liver |
| 02/01/2006 | EP1115849B1 Genes of the 1-desoxy-d-xylulose biosynthetic pathway |
| 02/01/2006 | CN1729289A Method of detecting gene mutation |
| 01/26/2006 | WO2005052130A3 Nrbps as modifiers of the rac pathway and methods of use |
| 01/26/2006 | WO2005052129A3 Diptheria toxin variant |
| 01/26/2006 | WO2005044978A3 Methods of treating, preventing and inhibiting cancer metastasis and tumor formation |
| 01/26/2006 | WO2005028618A3 Immunogenic compositions for streptococcus agalactiae |
| 01/26/2006 | WO2005019421A3 Crosslinking within coordination complexes |
| 01/26/2006 | WO2005001027A3 Compositions for down-regulation of ccr5 expression and methods of use therefor |
| 01/26/2006 | WO2004113505A3 System and method for sequence distance measure for phylogenetic tree construction |
| 01/26/2006 | WO2004113502A3 Identification of therapeutic agents using genetic fingerprinting |
| 01/26/2006 | WO2004113494A3 Methods for producing preparations of recombinant aav virions substantially free of empty capsids |
| 01/26/2006 | WO2004111202A3 Neurotransmission-association proteins |
| 01/26/2006 | WO2004104178A3 Efficient haploid cell sorting for flow cytometer systems |
| 01/26/2006 | WO2004094621A3 Polynucleotide encoding a novel trp channel family member, ltrpc3, and splice variants thereof |
| 01/26/2006 | WO2004087885A3 Method for transdifferentiation of non-pancreatic stem cells to the pancreatic pathway |
| 01/26/2006 | WO2004076636A3 A novel human g-protein coupled receptor, hgprbmy23, expressed highly in kidney |
| 01/26/2006 | WO2004072266A3 Antibody affinity engineering by serial epitope-guided complementarity replacement |
| 01/26/2006 | WO2004035732A3 Human polypeptides encoded by polynucleotides and methods of their use |
| 01/26/2006 | WO2004033669A3 Methods of manipulating nucleic acids |
| 01/26/2006 | US20060020398 Integration of gene expression data and non-gene data |
| 01/26/2006 | US20060020146 Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 01/26/2006 | US20060019384 Susceptible to baculovirus infection, useful for replicating, for gene expression using a baculovirus expression system |
| 01/26/2006 | US20060019256 Compositions and methods for treating and diagnosing cancer |
| 01/25/2006 | EP1618217A2 Bcl2l12 polypeptide activators and inhibitors |
| 01/25/2006 | EP1618190A2 Pathophysiology associated with a single gene (mass1) mutation underlying the robust audiogenic seizure phenotype in frings mice |
| 01/25/2006 | EP1618189A2 Rnai agents for anti-sars coronavirus therapy |
| 01/25/2006 | EP1618187A2 Multiply-primed amplification of nucleic acid sequences |
| 01/25/2006 | EP1618186A2 Genes upregulated in a tomato plant having an increased anthocyanin content phenotype |
| 01/25/2006 | EP1618185A2 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 01/25/2006 | EP1618184A2 Epha2, hypoproliferative cell disorders and epithelial and endothelial reconstitution |
| 01/25/2006 | EP1618181A2 Polyvalent protein complex |
| 01/25/2006 | EP1618180A2 Splice variants of human voltage-gated calcium channel alpha2delta-2 subunit designated-alpha2delta2-a and alpha2delta2-b |
| 01/25/2006 | EP1618179A2 Polymer-conjugated glycosylated neublastin |
| 01/25/2006 | EP1618177A2 Production of high mannose proteins in plant culture |
| 01/25/2006 | EP1617872A2 Methods and compositions for enhancing immune response |
| 01/25/2006 | EP1617870A2 Single chain antigen-binding polypeptides for polymer conjugation |
| 01/25/2006 | EP1617854A2 Biologically active native biomatrix composition |
| 01/25/2006 | EP1617777A2 Photomodulation methods and devices for regulating cell proliferation and gene expression |
| 01/19/2006 | WO2006005802A1 Method for stimulating mammalian cells and mammalian cell |
| 01/19/2006 | WO2005054436A3 Compositions and methods for preservation of vascular grafts |
| 01/19/2006 | WO2005038005A3 Shc proteins as therapeutic targets in proliferative diseases |
| 01/19/2006 | WO2005035723A3 Tyrosinase mutant and methods of use thereof |
| 01/19/2006 | WO2005017149A8 Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage site |
| 01/19/2006 | WO2004094620A3 Truncated baff receptors |
| 01/19/2006 | WO2004092398A3 Nucleic acid sequences encoding proteins associated with abiotic stress response and plant cells and plants with increased tolerance to environmental stress |
| 01/19/2006 | WO2004072267A3 Enzymes |
| 01/19/2006 | WO2004053074A3 Outcome prediction and risk classification in childhood leukemia |
| 01/19/2006 | US20060014763 Methods for altering mRNA splicing and treating familial dysautonomia and other mechanistically related disorders |
| 01/19/2006 | US20060014254 Albumin fusion proteins |
| 01/18/2006 | EP1616033A2 Dna polymerase fusions and uses thereof |
| 01/18/2006 | EP1616032A2 Detecting gene expression in live cells using short-lived reporters with enzymatic amplification |
| 01/18/2006 | EP1616017A2 A method for producing para-hydroxystyrene and other multifunctional aromatic compounds using two-phase extractive fermentation |
| 01/18/2006 | EP1615993A2 Methods of selection, reporting and analysis of genetic markers using broad based genetic profiling applications |
| 01/18/2006 | EP1615992A2 Prion protein binding materials and methods of use |
| 01/18/2006 | EP1615990A2 Multidimensional mass spectrometry of serum and cellular lipids directly from biologic extracts |
| 01/18/2006 | EP1615943A2 Compositions and methods for sirna inhibition of angiopoietin 1 and 2 and their receptor tie2 |
| 01/18/2006 | EP1594376A4 Filter containing a metal phthalocyanine and a polycationic polymer |
| 01/18/2006 | EP1395676B1 Viral drug susceptibility testing |
| 01/18/2006 | CN1721447A Modified peptides as therapeutic agents |